TAF8 and cancer: Interestingly, mutation of the m6A sites within TAF8 disrupts the interaction between hnRNPC and the TAF8 transcript, leading to an increase in the anti‐metastatic TAF8 L isoform and a decrease in the TAF8 S isoform, thereby limiting the metastatic potential of cancer cells.132